Insulet Receives CE Mark for the OmniPod(R) Insulin Managem...(ition with competitors; technological in...),Health

Date:4/28/2009

ition with competitors; technological innovations adversely affecting the Company's business; potential termination of Insulet's license to incorporate a blood glucose meter into the OmniPod System; Insulet's ability to protect its intellectual property and other proprietary rights; conflicts with the intellectual property of third parties, including claims that Insulet's current or future products infringe the proprietary rights of others; adverse regulatory or legal actions relating to the OmniPod System;; unfavorable results of clinical studies relating to the OmniPod System or the products of Insulet's competitors; potential future publication of articles or announcement of positions by physician associations or other organizations that are unfavorable to Insulet's products; the expansion, or attempted expansion, into foreign markets; the expansion of Insulet's distribution network; Insulet's ability to successfully maintain effective internal controls; and other risks and uncertainties described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on March 16, 2009 in the section entitled "Risk Factors," and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.

'/>"/>

SOURCE Insulet Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
2. Insulet Receives $60 Million Funding Commitment
3. Insulet Reports Fourth Quarter and Year End 2008 Results
4. Insulet Corporation to Report Fourth Quarter and Full Year 2008 Financial Results on Thursday, March 5, 2009
5. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
6. Insulet Reports Third Quarter 2008 Results
7. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
8. Sally W. Crawford Joins Insulets Board of Directors
9. Insulet Corporation to Report Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
10. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
11. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes